Q2 2026 Enovix Corp Earnings Call Transcript
Key Points
- Smartphone qualification milestone: Lead customer confirmed cells passed 1,000 cycles on the 0.2C discharge test, with final accelerated cycle life test expected to complete by end of 2026.
- Smart Eyewear commercial ramp: Shipped 2,100 batteries to a Tier 1 customer in Q2, with orders for ~19,000 packs in Q3 (9x increase) and a 50,000-unit order to be fulfilled by Q4.
- Drone/defense pipeline growth: Pipeline increased 41% QoQ to ~$180 million, with drone opportunities exceeding $100 million; over $40 million in active customer testing.
- Manufacturing yield improvements: Cumulative yield improved for three consecutive quarters; Zone 1 yield rose to 84% from 80%, with most process steps at 95%+ yields.
- Strong financial position: Ended Q2 with over $550 million in cash, enabling continued investment in qualification and capacity expansion.
- New COO Michael Vivoda (ex-Apple) hired to drive manufacturing, supply chain, and delivery improvements, enhancing operational execution.
- AI-driven cycle life prediction models in development to accelerate design iterations, potentially creating a durable competitive advantage.
- MX-B01 drone cell achieves ~360 Wh/kg, with UN 38.3 certification completed and customer sampling commencing in Q3.
- South Korea facility is TAA compliant and on track for NDAA compliance, a key advantage for defense contracts.
- Second smartphone OEM progressing toward qualification, with sample deliveries expected in Q4 2026.
- Smartphone qualification still incomplete: Final accelerated cycle life test (hybrid protocol) remains a gating item, with completion expected only by end of 2026.
- Smart Eyewear margins negative: Early ramp costs and low volumes will drag gross margins for the balance of 2026, with no clear breakeven point provided.
- Zone 1 dicing remains a bottleneck: Despite yield improvement to 84%, it is still a primary throughput constraint, with key mechanical dicing steps not online until year-end.
- Gross margin declined YoY in Q2: GAAP gross margin fell to 14% and non-GAAP to 18.9% due to product mix from South Korea, though first-half margins improved.
- Revenue growth modest: Q2 revenue of $9 million was only 21% YoY, and Q3 guidance of $9-10 million implies a sequential decline or flat growth.
- Dependence on a single lead customer for smartphone and Smart Eyewear ramps, creating concentration risk.
- Drone/defense revenue conversion timeline uncertain: While pipeline is large, revenue ramp is not expected until mid-2027, with defense primes taking up to 18 months.
- Operating losses persist: Non-GAAP loss from operations was $28.8 million in Q2, with Q3 guidance of $29-32 million loss, indicating continued cash burn.
- No share repurchases during the quarter, as capital deployment priorities shifted to qualification and manufacturing investments.
- Memory availability tightness (DRAM) could impact customer SKU strategies, though not yet affecting Enovix directly.
Corporation second quarter 2026 earnings conference call. Currently, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. As a reminder, today's program will be recorded.
And now, I'd like to introduce your host for today's program, Monica Gould, Investor Relations for Innovix. Please go ahead.
Thank you, operator. I would like to welcome everyone to Innovix Corporation's Second Quarter 2026 Financial Results Conference Call.
Joining me today are President and Chief Executive Officer, Dr. Raj Taluri and Chief Financial Officer, Ryan Benton. Raj and Ryan will be speaking to the slide presentation displayed on today's webcast, which will also be posted along with our press release on our investor relations website at ir.enovix.com.
They will provide prepared remarks, and we will then open the call for questions.
Before we begin, please note that today's call contains forward-looking statements that are subject to risks and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
